Gene Therapy for severe Hemophilia has new Phase I/II Results
uniQure has new data from the Phase I/II trial of its gene therapy for Hemophilia…
29/07/2016 - 3 minutes
Hemophilia
Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU
Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy…
17/05/2016 - 2 minutes
Global Hemophilia AID project achieves first milestone with donations from Swedish Biotech
The Hemophilia Aid Program has just touched down the first batch of treatments in its…
13/10/2015 - 3 minutes
Key-partnership for the most well-funded Biotech in Berlin
Berlin is growing as a massive Biotech hub, in part thanks to prestigious University of…
09/10/2015 - 2 minutes
Apitope relocates to Wales after €12M series B financing round
Now, as we've recently discussed here at Labiotech, there doesn't appear to be many Welsh…
30/09/2015 - 2 minutes
Sobi gets a long-lasting grip on a rare type of Hemophilia
In the 19th century, Queen Victoria passed the Hemophilia B to diverse royal houses of…
19/08/2015 - 3 minutes
Apitope’s peptide to take on Haemophilia A
Apitope’s pre-clinical candidate ATX-F8-117 has been granted Orphan Drug Status by the US FDA for…
09/06/2015 - 2 minutes
Bayer Healthcare invests €94 Million in its Hemophilia pipeline
Bayer HealthCare, a subgroup of Bayer AG, is one of the world's leading, innovative companies…
16/04/2015 - 2 minutes
